Business
Atria Oyj : Interim report (atria plc q1 2026 interim report)
Atria Oyj : Interim report (atria plc q1 2026 interim

About this update from Atria Oyj Class A
ATRIA PLC INTERIM REPORT 1 January - 31 March 2026 Q1 Atria Group's net sales and EBIT increased in the first quarter January-March 2026 Consolidated net sales grew by 7.1% to EUR 450.3 million (EUR 420.5 million). Atria Finland's net sales increased by 8.1% from the corresponding period last year. Growth was supported by good sales development in all sales channels; in particular, sales to retail customers strengthened. Atria Sweden's net sales also grew. The strengthened Swedish krona increased the net sales in euros. The avian influenza epidemic in Sweden at the end of 2025 weakened the availability of poultry meat during the review period. Availability problems had a negative effect on Atria Sweden's net sales. Atria Denmark & Estonia's net sales were lower than the comparison period. The Group's consolidated EBIT amounted to EUR 13.9 million (EUR 12.8 million), or 3.1% (3.1%) of net sales. Atria Finland's EBIT fell by EUR 0.6 million from the comparison period. Atria Finland's earnings performance was weakened by the market imbalance in Europe due to oversupply of pork. In addition, the result was affected by a general rise in costs. Despite supply issues with poultry meat, Atria Sweden's EBIT grew by EUR 0.8 million, thanks to effective sales and marketing measures and a favourable sales structure. Atria Denmark & Estonia's EBIT increased by EUR 0.9 million as a result of Atria Estonia's good result. Atria has continued the determined implementation of its TOGETHER 2030 strategy. In March, Atria Sweden acquired a 25% stake in the Swedish convenience food company Cookin Food Sweden AB. Investments in Nurmo, Kauhajoki and Sköllersta proceeded as planned. Atria and its contract producers have reduced carbon dioxide emissions from poultry and pork production by 8% since 2020. These reductions are primarily due to a significant decrease in the use of soy in feed, improved feed efficiency, and increased use of renewable energy. The Board of Directors proposes to the Annual General Meeting that a dividend of EUR 0.75 (EUR 0.69) per share be distributed for the 2025 financial period. EUR million Q1 Q1 2026 2025 2025 Net sales Atria Finland 332.8 307.7 1,319.6 Atria Sweden 93.4 88.9 392.7 Atria Denmark & Estonia 29.0 29.8 124.8 Eliminations -4.9 -6.0 -23.3 Net sales, total 450.3 420.5 1,813.7 EBIT before items affecting comparability Atria Finland 10.7 11.2 62.2 Atria Sweden 1.5 0.7 8.3 Atria Denmark & Estonia 2.6 1.8 4.9 Unallocated -0.8 -0.9 -5.5 Adjusted EBIT 13.9 12.8 69.9 Adjusted EBIT, % 3.1 % 3.1 % 3.9 % Items affecting comparability of EBIT: Atria Finland Disposal and restoration of the Kuopio factory area -5.9 EBIT 13.9 12.8 64.0 EBIT, % 3.1 % 3.1 % 3.5 % Profit before taxes 12.4 10.1 53.6 Earnings per share, EUR 0.35 0.28 1.44 Adjusted earnings per share, EUR 0.35 0.28 1.61 CEO, Kai Gyllström "Atria Group's year started strongly: both our net sales and EBIT improved in the first quarter. The Group's net sales increased to EUR 450.3 million and the EBIT was EUR 13.9 million, which corresponds to 3.1% of net sales. The growth of net sales was driven in particular by significant sales growth at Atria Finland across all sales channels, especially in the retail channel. Net sales of Atria Finland increased by 8.1% from the corresponding period in the previous year, and Atria Sweden's net sales also strengthened. Atria Denmark & Estonia's net sales fell slightly. Overall, the result was good. Atria Sweden's EBIT improved by EUR 0.8 million, despite problems affecting the supply of poultry meat. The favourable sales structure and successful sales and marketing measures strengthened the result in Sweden. Atria Denmark & Estonia's EBIT improved from the comparison period. The efficiency of operations was improved in Estonia, and the prices of raw materials were at a low level. In addition, Atria Estonia received more subsidies related to the improvement of animal welfare than in the comparison period. Atria Finland's EBIT fell by EUR 0.6 million, due to a market imbalance in Europe caused by an oversupply of imported pork and a general rise in costs. In Sweden, avian influenza that spread to poultry production facilities at the end of 2025 significantly reduced the availability of poultry between January and March. Supply challenges negatively affected our net sales and result in Sweden. The disease situation has since stabilised and the availability of domestic poultry meat in Sweden is returning to normal levels. The African swine fever that occurred in Estonia last summer caused disturbances in the operations of Atria Estonia. However, the disease situation has now calmed down, and Atria has managed to effectively overcome the effects of the epidemic. The situation was handled in close cooperation with the authorities, and at the same time extensive measures have been taken to strengthen biosafety in the changed operating environment. We have continued to implement our TOGETHER 2030 strategy with determination. Atria strengthened its position in convenience food in Sweden when we bought a 25% stake in Cookin Food Sweden AB in March. Cookin produces fresh convenience food, and the company is known for bespoke product solutions, high quality and fresh ingredients. This acquisition is an opportunity to expand our product range with new types of convenience food products. Atria has the option to buy the remaining shares after 2028. Our investments in Nurmo, Kauhajoki and Sköllersta also progressed according to plan. During the review period, we launched several new, innovative products. In the Swedish retail trade, Atria introduced a completely new concept based on Sibylla classics, enabling the preparation of popular street food dishes at home. In Finland, two modern hybrid minced meat products were launched in retail trade: Chicken-fava bean and beef-chicken minced meats. The new products met consumers' evolving expectations and were positively received by the market. We continued to work towards our sustainable goals: based on updated carbon footprint calculations, Atria and its contract producers in Finland manage to reduce the carbon dioxide emissions from their poultry and pork production by 8% between 2020 and 2024. These reductions primarily result from a significant decrease in the use of soy in feed, improved feed efficiency, and increased use of renewable energy. At the end of the review period, uncertainty was heightened by the conflict in the Middle East that began in February. Increased geopolitical tensions are expected to weigh on consumer confidence and increase caution in markets. At the same time, cost pressures are increasing throughout the food supply chain. We closely monitor developments in our operating environment and ensure our competitiveness and delivery reliability even in a changing market situation." January-March 2026 Atria Group's net sales in January-March were EUR 450.3 million (EUR 420.5 million), increasing by 7.1% from the comparison period. EBIT totalled EUR 13.9 million (EUR 12.8 million), or 3.1% (3.1%). Atria Finland's net sales grew by 8.1% from the same period in the previous year. Growth was supported by good sales development in all sales channels; in particular, sales to retail customers strengthened. Sales of Foodservice products, as well as exports and industrial trade, also grew strongly. The oversupply of pork in Europe continued during the review period and weighed on international market prices. The beef market continued to be demand-driven, with demand focusing particularly on minced meat. Atria Sweden's net sales improved from the comparison period. In the local currency, net sales grew by 0.2% from the corresponding period last year. In Sweden, the avian influenza epidemic detected at the end of 2025 continued until the beginning of January 2026, which reduced the supply of poultry meat. Poultry meat supply problems had a negative effect on the development of Atria Sweden's net sales during the review period. In contrast, the strong sales performance of Gooh! convenience food products strengthened the sales. Atria Denmark & Estonia's net sales were lower than in the comparison period. Atria Estonia's net sales increased compared to the corresponding period of the previous year. Atria Denmark's sales to retail trade and Foodservice customers were at the previous year's level. The value of exports was lower than in the corresponding period of the previous year. Atria Group's EBIT developed well during the review period. Atria Finland's EBIT for the review period fell by EUR 0.6 million from the comparison period. Earnings were particularly impacted by the challenging situation in the international pork market and the general rise in costs. Despite supply issues affecting poultry meat, Atria Sweden's EBIT for the review period increased by EUR 0.8 million. Successful sales and marketing measures and a favourable sales structure across distribution channels and product categories strengthened Atria Sweden's EBIT. The good development of the Gooh! business also strengthened Atria Sweden's result. Atria Denmark & Estonia's EBIT increased by EUR 0.9 million from the comparison period. The growth in Atria Estonia's EBIT was supported by lower raw material prices and improved production efficiency. In addition, Atria Estonia received approximately EUR 1.2 million (EUR 0.4 million) in animal welfare related subsidies in January. Atria Denmark's EBIT was lower than in the comparison period. In March, Atria Sweden acquired a 25% stake in the Swedish convenience food company Cookin Food Sweden AB. The investments launched by Atria in 2025 in convenience food production at the Nurmo plant, beef production at the Kauhajoki plant and meat products at the Sköllersta plant are proceeding in schedule as planned. Atria Plc transferred a total of 30,194 Atria Plc shares held by the company, free of charge, as a reward to the Group's key employees in the target group for the 2023, 2024 and 2025 earnings periods of the share-based incentive scheme. After the transfer of the shares, the company holds 33,580 of its own shares. Sustainability: aiming for a carbon neutral food supply chain Atria published its 2025 Sustainability Statement, prepared in accordance with the Corporate Sustainability Reporting Directive (CSRD), on 11 March 2026, as part of the Board of Directors' report. The report can be found on Atria's website at: https://www.atria.com/en/investors/financial-information/annual-reports/ A carbon neutral food chain is the most important goal of Atria's sustainability work. Atria's emissions reduction targets have been officially approved by the Science Based Targets (SBTi) initiative. The targets are based on the Paris Climate Agreement and aim to limit global warming to 1.5 degrees Celsius globally. In the targets approved by SBTi, Atria commits to reducing greenhouse gas emissions from its own operations (Scopes 1 and 2) by 42% by 2030 from 2020 levels. The reduction target for Scope 3 emissions is 20% per tonne of processed meat by 2030. Atria and contract producers cut the carbon footprint of production by 8 per cent Atria and its contract producers in Finland have reduced carbon dioxide emissions from poultry and pork production by 8% since 2020, according to the updated carbon footprint calculations for 2024. These reductions primarily result from a significant decrease in the use of soy in feed, improved feed efficiency, and increased use of renewable energy. Reduction of the carbon footprint of poultry production: 2.56 kg CO₂e/kg in 2020 => 2.35 kg CO₂e/kg in 2024. Reduction of the carbon footprint of pork production: 3.21 kg CO₂e/kg in 2020 => 2.96 kg CO₂e/kg in 2024. Atria continues to expand the carbon footprint calculations of beef production with the aim of more comprehensive reporting in the future. Atria Finland has been awarded the ISO 45001 occupational health and safety certificate Being awarded the certificate confirms that Atria Finland's occupational safety management meets the requirements of the international standard. The certificate covers Atria Finland's operations and is a tangible recognition of long-term efforts to achieve a safe and healthy working environment. Market trends The table below shows Atria's producer share by business area (the combined share of Atria's own brands and private-label products made by Atria) in the retail trade in terms of value. The figures in brackets show the total producer share for the corresponding period last year across the product categories we represent. The table also shows the retail market development (%) in terms of value and quantity (kg) for Atria's product categories by business area compared to the corresponding period last year. The measurement period is January-March 2026. Source: Atria Market Insight and NIQ Finland Market development in value 1-3/2026 Market development, kg 1-3/2026 Atria's producer share by value (%) 1-3/2026 Consumer packed red meat +14.4% -3.0% 36.7% Consumer packed poultry +4.1% +3.5% 41.9% Sausages and other meat products +0.2% -0.1% 26.0% Cold cuts +0.1% -1.0% 20.8% Convenience food +6.1% +4.1% 13.6% Atria's product categories, total +5.6% +1.6% 25.2% (25.0%) Sweden 1-3/2026 1-3/2026 1-3/2026 Fresh poultry +19.2% +8.1% 16.0% Sausages +2.0% -0.7% 24.4% Cold cuts +2.6% +0.1% 12.1% Fresh convenience food +4.7% -0.4% 24.3% Atria's product categories, total +6.7% +1.8% 17.7% (17.3%) Estonia 1-3/2026 1-3/2026 1-3/2026 Fresh meat (excluding poultry) +8.7% +9.4% 28.1% Marinated meat +10.0% +3.4% 15.9% Sausages +1.1% -0.9% 24.2% Convenience food components +3.4% -0.1% 17.8% Cold cuts +1.8% -0.1% 20.3% Atria's product categories, total +4.5% +2.8% 21.7% (22.1%) Denmark 1-3/2026 1-3/2026 1-3/2026 Cold cuts +0.9% -0.5% 12.0% (13.0%) Atria Finland There was a clear upturn in the retail trade of Atria's product categories. The market as a whole grew by 5.6% in euros and 1.6% in kilograms. The market for consumer-packaged meat grew by more than 14% in value. Convenience food grew by more than 6 % in value. The cold-cuts market, which declined throughout last year, has now stabilised and is at the same level as a year ago. Atria's producer share in the retail trade for its product categories was 25.2%. The Foodservice market has remained more subdued than the retail trade. The Foodservice market grew by 2.8% in value but fell by 1.5% in kilograms. Atria Sweden In January-March, the total market for Atria's product categories in the Swedish retail trade grew by 6.7% in value and 1.8% in volume. The fresh poultry market continued its strong growth: the market grew by 19.2% in value and 8.1% in volume. The first quarter was challenging, especially in poultry products, as the supply of raw material was poor due to avian flu. The reduced availability of domestic raw material has increased poultry imports in the Swedish retail sector during the review period. Atria's producer share in the Swedish retail trade (the combined share of Atria's own brands and private label products produced by Atria) was 17.7%. In January-February, the Swedish Foodservice market grew by 1.5% in value compared to the corresponding period in the previous year. Atria Estonia In Estonia, the market for Atria's product categories grew by an average of 4.5% in value in January-March. Atria's market share in the Estonian retail trade, measured by value, was 21.7% in January-March, or 0.4 percentage points lower than in the previous year. Atria Denmark The market for cold cuts in the Danish retail trade grew by 0.9% in value, while the market contracted by 0.5% in volume. The retail producer share of Atria Denmark was 12.0% during the review period. Business development by business area, January-March 2026 Atria Finland EUR million Q1 Q1 2026 2025 2025 Net sales 332.8 307.7 1,319.6 Adjusted EBIT 10.7 11.2 62.2 Adjusted EBIT, % 3.2 % 3.6 % 4.7 % Items affecting comparability of EBIT: Disposal and restoration of the Kuopio factory area -5.9 EBIT 10.7 11.2 56.3 EBIT, % 3.2 % 3.6 % 4.3 % Atria Finland's net sales for January-March were EUR 332.8 million (EUR 307.7 million). Net sales grew by 8.1% from the corresponding period last year. Growth was supported by good sales development in all sales channels; in particular, sales to retail customers strengthened. Sales of Foodservice products, as well as exports and industrial trade, also grew strongly. The oversupply of pork in Europe continued during the review period and weighed on international market prices. The beef market continued to be demand-driven, with demand focusing particularly on minced meat. EBIT totalled EUR 10.7 million (EUR 11.2 million). EBIT for the period fell by EUR 0.6 million from the comparison period. Earnings were particularly impacted by the challenging situation in the international pork market and the general rise in costs. The rise in costs weighed on the result; expenses related to own operations and outsourced services were influenced, among other factors, by the cumulative effect of wage settlements adopted in recent years, general cost inflation and increases in operating expenses (including energy and water). The investment in Atria's new convenience food factory proceeded as planned during the review period. Construction work is on schedule, the groundwork has mainly been completed and the building is beginning to take shape. Contracts for the project have been agreed, and the foundation stone was laid on 19 January 2026. The project will be completed during 2028. Investments in pancake production and the Kauhajoki cattle slaughterhouse also progressed as planned during the review period. Construction and building services works are underway on the pancake production line, and the equipment has largely been procured. After demolition work in Kauhajoki, construction work started, and the installation of prefabricated construction units was underway at the end of the review period. In March, Atria Finland was awarded the ISO 45001 occupational health and safety certificate. The certificate covers Atria Finland's operations and supports the systematic development of a safe and healthy working environment as part of responsible business. Atria Sweden EUR million Q1 Q1 2026 2025 2025 Net sales 93.4 88.9 392.7 EBIT 1.5 0.7 8.3 EBIT, % 1.6 % 0.8 % 2.1 % Atria Sweden's net sales for January-March were EUR 93.4 million (EUR 88.9 million). In the local currency, net sales grew by 0.2% from the same period last year. In Sweden, the avian influenza epidemic detected at the end of 2025 continued until the beginning of January 2026. The outbreak significantly reduced the availability of poultry meat on the Swedish market during the first quarter for all poultry meat processors, including Atria. Poultry meat supply problems had a negative effect on the development of Atria Sweden's net sales during the review period. In contrast, the strong performance of Gooh! convenience food products boosted sales. EBIT totalled EUR 1.5 million (EUR 0.7 million). Atria Sweden's EBIT was strengthened by successful sales and marketing measures, as well as a favourable sales structure across different distribution channels and product categories. The favourable development of the Gooh! business contributed to Atria Sweden's good result. Problems affecting the supply of poultry meat had a negative impact on EBIT during the review period. Energy costs were also higher than in the corresponding period of the previous year, and raw material costs, especially beef prices, remained high. In March, Atria acquired a 25% stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction was carried out by acquiring shares in Bite Delight AB, which owns Cookin Food Sweden AB. After the acquisition, Cookin will be reported as an associated company. Atria also has the option to buy the remaining shares of Bite Delight AB after 2028. The acquisition is in line with Atria's TOGETHER 2030 strategy, which is to focus on growing product categories. Convenience food is one of the fastest-growing product categories, and the company is aiming for strong growth in its convenience food business. Cookin Food Sweden AB's net sales are approximately EUR 18 million. The company's main products are salads and sandwiches sold to the Swedish retail trade, as well as to Foodservice and transport service customers. The product offering also includes sushi, commercial kitchen products and pies. In March, Atria launched a concept based on Sibylla classics for the Swedish retail trade. It is a completely new concept that enables the cooking of street food favourites at home. The investment of approximately EUR 23 million in the production of meat products at the Sköllersta plant, launched in December 2025, is proceeding as planned. The investment encompasses a new continuously operating production line, as well as an expansion and upgrade of the production site in Sköllersta. The investment replaces old production equipment, and improves energy efficiency, product quality and the reliability of deliveries. The investment will be completed in the first quarter of 2027. Atria Denmark & Estonia EUR million Q1 Q1 2026 2025 2025 Net sales 29.0 29.8 124.8 EBIT 2.6 1.8 4.9 EBIT, % 9.0 % 5.9 % 4.0 % Atria Denmark & Estonia 's net sales in January-March were EUR 29.0 million (EUR 29.8 million). EBIT totalled EUR 2.6 million (EUR 1.8 million). Atria Estonia's net sales and EBIT increased from to the corresponding period last year. The increase in EBIT in Estonia was supported by lower raw material prices and improved production efficiency. In addition, Atria received approximately EUR 1.2 million (EUR 0.4 million) in animal welfare subsidies in January. Atria Denmark's sales to retail trade and Foodservice customers were at the previous year's level. The value of exports was lower than in the corresponding period of the previous year. EBIT was lower than in the comparison period. Raw material prices have remained stable during the review period. Atria's market share in Estonian retail trade measured in value was 21.7% in January-March which is 0.4 percentage points lower than last year. The main reason for the decrease in market share is the increased share of private label products in the market. In Estonia, the greatest growth in sales of Atria products was in hams and sausages. In the first quarter, the sales volume of smoked sausages increased the most, rising by 19%. In addition, the volume of hams increased by 7%. The Danish market for cold cuts contracted in volume but increased in value. Atria Denmark's producer share in the cold cuts market was 12.0% during the review period. Group key indicators EUR million Q1 Q1 2026 2025 2025 Net sales 450.3 420.5 1813.7 Adjusted EBIT 13.9 12.8 69.9 Adjusted EBIT, % 3.1 % 3.1 % 3.9 % EBIT 13.9 12.8 64.0 EBIT, % 3.1 % 3.1 % 3.5 % EPS, EUR 0.35 0.28 1.44 Adjusted EPS, EUR 0.35 0.28 1.61 Shareholders´ equity per share EUR 15.75 14.64 15.32 Adjusted return on equity (rolling 12m), % 11.3 % 11.2 % 11.0 % Adjusted return on investment (rolling 12m), % 10.7 % 10.7 % 10.5 % The principles for calculating the indicators are presented at the end of the report. Personnel During the review period, the recruitment of summer workers started in all Atria's business areas. Atria hires about 1,000 summer workers for the summer season. Personnel by Business Area Q1 Q1 average FTE 2026 2025 2025 Atria Finland 2,443 2,442 2,463 Atria Sweden 864 863 880 Atria Denmark & Estonia 444 425 442 Total 3,751 3,730 3,785 Financial position Key figures of financing EUR million Q1 Q1 2026 2025 2025 Cash flow from operating activities -4.9 17.5 120.0 Cash flow from investing activities -22.5 -5.9 -50.2 Free cash flow -27.4 11.7 69.8 Gross investments 19.1 8.4 54.2 Net debt 265.6 255.5 218.7 Net gearing, % 56.7 % 58.5 % 48.1 % Finance cost, net 2.2 3.2 10.7 Net debt/adjusted EBITDA 1.96 1.92 1.64 Equity ratio, % 45.5 % 42.8 % 45.7 % Average interest rate of the loan portfolio, % 3.34% 3.65% 3.36% The principles for calculating the indicators are presented at the end of the report. The Group's interest-bearing net debt on 31 March 2026 amounted to EUR 265.6 million (31 December 2025: EUR 218.7 million). During the review period, the Group's free cash flow was EUR -27.4 million (EUR 11.7 million). Cash flow from operations was EUR -4.9 million (EUR 17.5 million). Cash flow from operations weakened by EUR 22.4 million during the review period. This was mainly due to the seasonal increase in working capital items in the early part of the year. Cash flow from investments was EUR -22.5 million (EUR -5.9 million). At the end of the period, the equity ratio was 45.5% (31 December 2025: 45.7%). The change in the fair value of the effective portion of derivative instruments used as hedges and included in equity amounted to EUR 3.9 million (EUR -0.4 million). The Group's liquidity remained good during the period. On 31 December 2026, the Group's undrawn committed credit facilities stood at EUR 50.0 million (31 December 2025: EUR 50.0 million), and no loans were drawn from them during 2026. Atria also has a EUR 200 million commercial paper programme, which was used for short-term financing. The average maturity of drawn loans and committed credit facilities at the end of the review period was 3 years and 4 months (31 December 2025: 3 years 7 months). Atria has hedged against rising interest rates with interest rate derivatives, which stood at EUR 110 million on 31 March 2026 (31 December 2025: EUR 110 million). At the end of March, the Group's fixed-interest debt represented 47.8% of the loan portfolio (31 December 2025: 47.6%). Some loans have been converted into fixed interest-rate loans with derivatives valued at fair value. The net financing costs for the first quarter were EUR -2.2 million (EUR -3.2 million). The average interest rate for the loan portfolio on 31 March 2026 was 3.34% (31 December 2025: 3.36%). Business risks during the review period and the near term Atria Group's business, net sales and result can be affected by many uncertainties. Atria describes its business risks and risk management in detail in its Annual Report 2025, which is available at https://www.atria.com/en/investors/financial-information/annual-reports/ . During the review period, uncertainty has significantly increased due to the conflict in the Middle East that started in February 2026. The conflict is particularly reflected in the energy markets and oil price development, which have a direct impact on Atria's transport costs throughout the food supply chain. In addition, there are cost pressures on packaging materials as well as primary production, including the prices of feed components, fertilisers and fuels. In addition, uncertainty continued due to both the continuation of Russia's war of aggression in Ukraine and the escalation of global geopolitical tensions. Combined with the unstable US tariff policy, these affected market behaviour and consumers' purchasing decisions and confidence. In 2025, China imposed import duties on European pork, which affected the pork market, with more products remaining on the European market. In addition, African swine fever was detected in Spain in the last quarter of 2025. For these reasons, pork prices in Europe fell during the second half of 2025, and the pork market is expected to remain unstable at least for the first half of 2026. During the review period, animal disease risks in Finland and nearby areas remained moderate. In Sweden, there was an avian influenza epidemic at the end of 2025, which significantly reduced the supply of poultry on the Swedish market during the first quarter. The situation has now stabilised and the supply of poultry in Sweden is returning to normal, but there is still a risk that the epidemic will continue. Last year, there was an outbreak of African swine fever in Estonia. At the moment, the situation is calm, but the risk of the disease remains. Atria actively monitors the animal disease situation in Europe. Atria has protective measures in place in its own production plants and on its contract farms . European beef production has declined in recent years, while consumption has remained unchanged. This is creating an imbalance in the beef market. The fight against cybercrime and information system disruptions requires continuous development and a proactive approach. Systematic monitoring is key, as it enables the timely detection of threats. The continuous improvement of cybersecurity through system upgrades, employee training and the introduction of new technologies is also very important. Future outlook and guidance In 2026, Atria Group's adjusted EBIT is expected to be higher than in the previous year (EUR 69.9 million). Atria's good market position, strong brands and good customer relationships, as well as reliable industrial processes, create the conditions for the positive development of EBIT also in 2026. Cost inflation caused by the crisis in the Middle East, the unstable European pork market, animal disease risks and low consumer confidence in Atria's domestic markets are risk factors that may affect the EBIT in the near future. Resolutions of the Annual General Meeting 2025 The resolutions of the Annual General Meeting were published in a stock exchange release on 24 April 2025. The release is available on the Investors page of Atria's website at: https://www.atria.com/en/investors/general-meetings/annual-general-meeting-2025/ . Shares and current authorisations Atria Plc's share capital consists of 28,267,728 shares, divided into 19,063,747 series A shares and 9,203,981 series KII shares. Each series A share entitles its holder to one (1) vote at a General Meeting and each series KII share to ten (10) votes. Atria Plc's shareholders are entitled to a total of 111,103,557 votes. At the end of the review period, the company held 33,580 (63,774) of its own series A shares. In March, the company transferred 30,194 of its treasury shares to the Group's key personnel, who were the target group of the share-based incentive scheme, as a reward without consideration. The General Meeting decided, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to decide on the acquisition of a maximum of 2,800,000 of the company's series A shares, in one or more instalments, using funds from the company's unrestricted equity. However, this is subject to the provisions of the Limited Liability Companies Act on the maximum number of treasury shares that can be held by a company. The company's series A shares may be acquired for use as consideration in any acquisitions or other arrangements related to the company's business, to finance investments, as part of the company's incentive scheme, to improve the company's capital structure, to be otherwise further assigned, to be retained by the company or to be cancelled. The shares must be acquired in a proportion other than that of the shareholders' current shareholdings in the company in public trading arranged by Nasdaq Helsinki Ltd at the market price at the time of acquisition. The shares must be acquired and paid for in accordance with the rules of Nasdaq Helsinki Ltd and Euroclear Finland Oy. In all other respects, the Board of Directors is authorised to decide on the acquisition of treasury shares. The authorisation supersedes the authorisation granted by the AGM on 23 April 2024 to the Board of Directors to decide on the acquisition of treasury shares, and it will remain valid until the closing of the next AGM or 30 June 2026, whichever is first. In accordance with the Board of Directors' proposal, the AGM authorised the Board of Directors to decide, on one or more occasions, on an issue of a maximum of 2,800,000 new series A shares or on the disposal of any series A shares held by the company through a share issue and/or by granting option rights or other special rights entitling people to shares as referred to in Chapter 10, section 1 of the Limited Liability Companies Act. The authorisation is intended to be used for the financing or execution of any acquisitions or other arrangements or investments relating to the company's business, for the implementation of the company's incentive programme or for other purposes subject to a decision by the Board. The Board is also authorised to decide on all terms and conditions of the share issue and of the granting of special rights as referred to in Chapter 10, section 1 of the Companies Act. The authorisation thus also includes the right to issue shares in a proportion other than that currently held by the shareholders under the conditions provided by law, the right to issue shares against or without payment and the right to decide on a share issue to the company itself without payment, subject to the provisions of the Limited Liability Companies Act regarding the maximum number of treasury shares to be held by a company. The authorisation supersedes the share issue authorisation granted to the Board of Directors by the AGM on 23 April 2024 and will be valid until the closing of the next AGM or 30 June 2026, whichever comes first. In accordance with the proposal of the Board of Directors, the Annual General Meeting resolved to authorise the Board of Directors to donate a maximum of EUR 100,000 of the company's distributable funds to support the activities of colleges, universities or other educational institutions, or to support other charitable or similar purposes. At the same time, the Board of Directors was authorised to decide the payment schedules of donations and any other terms and conditions of the donations. The Board of Directors' proposal for dividend distribution for 2025 The Board of Directors proposes that a dividend of EUR 0.75 (EUR 0.69) be paid for each share for the 2025 financial period. Financial reports for 2026 and the Annual General Meeting 2026 The Annual General Meeting will be held on 23 April 2026. In 2026, Atria Plc will publish a half-year report and one more interim report: Half-year report January-June on 22 July 2026 at approximately 8:00 a.m. Interim report for January-September on 22 October 2026 at approximately 8:00 a.m. Financial releases will also be available on the company's website at https://www.atria.com immediately after release. Proposals of the Nomination Committee to the Annual General Meeting 2026 The Nomination Committee proposes to the General Meeting that a total of eight members be elected to the Board of Directors. The Nomination Committee notes that the 2025 Annual General Meeting decided to amend the company's Articles of Association as proposed by the Board of Directors so that the term of all Board members ends at the conclusion of the 2026 Annual General Meeting. Seppo Paavola and Kjell-Göran Paxal have announced that they are no longer available for re-election as Board members. The Nomination Committee proposes to the Annual General Meeting that Mika Joukio, Jukka Kaikkonen, Juha Kiviniemi, Nina Kopola, Pasi Korhonen and Leena Laitinen be re-elected as members of the Board of Directors. The Nomination Committee proposes to the Annual General Meeting that Sofie Dalkarl and Juha Savela be elected as new members of the Board of Directors. The proposal concerning the composition of the Board of Directors complies with the provision of the Limited Liability Companies Act and Recommendation 8 of the Corporate Governance Code, as both genders are represented by three or more members of the proposed eight-member Board and, in addition, the principles regarding the Board's diversity have been taken into account. The Nomination Committee proposes to the Annual General Meeting that the remuneration of the members of the Board of Directors remain unchanged. The fees and compensation for meeting expenses are as follows: Meeting compensation: EUR 350 per meeting Compensation for loss of working time: EUR 300 for meeting and proceeding dates Fee of the Chair of the Board of Directors: EUR 5,200 per month Fee of the Deputy Chair: EUR 3,000 per month Fee of a member of the Board of Directors: EUR 2,700 per month Travel allowance according to the company's travel policy The Nomination Committee proposes to the Annual General Meeting that the remuneration of members of the Supervisory Board remain unchanged. The fees and compensation for meeting expenses are as follows: Meeting compensation: EUR 350 per meeting Compensation for loss of working time: EUR 300 for meeting and proceeding dates Fee of the Chair of the Supervisory Board: EUR 1,700 per month Fee of the Deputy Chair: EUR 850 per month Travel allowance according to the company's travel policy The compensation for the meeting expenses is also paid to the chair and deputy chair of the Supervisory Board when they attend any meetings of the company's Board of Directors. The Nomination Committee proposes to the Annual General Meeting that the Annual General Meeting approve the proposal for the rules of procedure of the Shareholders' Nomination Committee annexed to the stock exchange release published on 12 January 2026. The Nomination Committee proposes some changes to the rules of procedure to improve the nomination process and update them to meet the requirements of the revised Corporate Governance Code, for example. Composition of Atria Plc's Nomination Committee The following were elected to Atria Plc's Nomination Committee, appointed by the Annual General Meeting: Juho Anttikoski, Farmer, representative of Itikka Co-operative Pasi Korhonen, Farmer, representative of Lihakunta Ola Sandberg, Farmer, representative of Pohjanmaan Liha Hanna Kaskela, SVP, Sustainability and Communications, representative of Varma Mutual Pension Insurance Company At its first meeting, the Nomination Committee elects a chairperson from among its members. The Nomination Committee prepares proposals to the next Annual General Meeting regarding the remuneration of the members of the Board of Directors and the Supervisory Board as well as the election of the members of the Board of Directors. The Nomination Committee submitted its proposal to the Board by 1 February 2026. Shareholders or their representatives who own Series KII shares, as well as the largest holder of Series A shares who does not own Series KII shares, or a representative thereof, are elected to the Nomination Committee in accordance with their ownership in early September preceding the next Annual General Meeting. If the largest holder of Series A shares does not wish to exercise his or her right to nominate a member, the right will be transferred to the next largest Series A shareholder. Itikka Co-operative, Lihakunta and Pohjanmaan Liha Co-operative are Series KII shareholders. Some shareholders are obligated to notify the company of certain changes in shareholding when necessary under the Finnish Securities Markets Act (notification obligation). Such shareholders may present a written request to the Company's Board of Directors by the end of August for the holdings of corporations or foundations controlled by the shareholder, or the shareholder's holdings in several funds or registers, to be combined when calculating voting rights. A shareholder with nominee-registered shares is considered when defining the composition of the Nomination Committee, if the holder of nominee-registered shares presents a request regarding the matter to the company's Board of Directors by the end of August preceding the Annual General Meeting. Corporate governance principles Atria's Corporate Governance Principles and information on deviations from the Finnish Corporate Governance Code are available on the company's website at https://www.atria.com . ATRIA PLC Board of Directors For more information , please contact: Kai Gyllström, CEO, Atria Plc. Contacts and interview requests via Communications Manager Marja Latvatalo, e-mail: [email protected] , tel.: +358 400 777 874. DISTRIBUTION Nasdaq Helsinki Ltd Major media https://www.atria.com The interim report is available on our website at https://www.atria.com . ATRIA PLC INTERIM REPORT TABLES 1 January - 30 March 2026 Q1 Interim report 1 January - 31 March 2026 17 Consolidated income statement EUR million 1-3/2026 1-3/2025 1-12/2025 Net sales 450.3 420.5 1,813.7 Costs of goods sold -405.3 -377.2 -1,615.8 Gross profit 45.0 43.3 198.0 Sales and marketing expenses -18.0 -16.9 -72.2 Administrative expenses -15.1 -13.8 -58.4 Other operating income 2.0 0.9 4.5 Other operating expenses -0.0 -0.6 -7.8 EBIT 13.9 12.8 64.0 Finance income and costs -2.2 -3.2 -10.7 Income from joint ventures and associates 0.7 0.5 0.2 Profit before taxes 12.4 10.1 53.6 Income taxes -1.9 -1.7 -10.0 Profit for the period 10.5 8.4 43.6 Profit attributable to: Owners of the parent 9.8 7.9 40.7 Non-controlling interests 0.7 0.5 2.9 Total 10.5 8.4 43.6 Basic earnings per share, EUR 0.35 0.28 1.44 Diluted earnings per share, EUR 0.35 0.28 1.44 Consolidated statement of EUR million 1-3/2026 1-3/2025 1-12/2025 Profit for the period 10.5 8.4 43.6 Other comprehensive income after tax: Items that will not be reclassified to profit or loss Actuarial losses from benefit-based pension obligations 0.0 0.0 0.6 Items reclassified to profit or loss when specific conditions are met Cash flow hedges 3.9 -0.4 1.1 Currency translation differences -1.3 5.8 6.1 Total comprehensive income for the period 13.1 13.8 51.3 Total comprehensive income attributable to: Owners of the parent 12.4 13.3 48.4 Non-controlling interests 0.7 0.5 2.9 Total 13.1 13.8 51.3 Consolidated statement of financial position Assets EUR million 31.3.2026 31.3.2025 31.12.2025 Non-current assets Property, plant and equipment 534.8 524.7 530.1 Biological assets 0.5 0.6 0.5 Right-of-use assets 35.1 25.0 17.9 Goodwill 84.0 84.4 84.5 Other intangible assets 58.8 61.0 59.7 Investments in joint ventures and associates 24.5 21.7 21.1 Other financial assets 3.7 3.0 3.7 Trade receivables, loan and other receivables 12.4 9.9 8.6 Deferred tax assets 3.5 2.7 3.5 Total 757.3 732.9 729.5 Current assets Inventories 135.0 129.5 128.3 Biological assets 5.4 5.5 4.5 Trade and other receivables 132.8 125.2 106.2 Cash and cash equivalents 0.3 27.5 30.9 Total 273.6 287.7 269.9 Total assets 1,030.9 1,020.7 999.4 Equity and liabilities 31.3.2026 EUR million 31.3.2025 31.12.2025 Equity attributable to the shareholders of the parent company 444.7 414.9 432.0 Non-controlling interests 23.5 21.8 22.8 Total equity 468.2 436.6 454.8 Non-current liabilities Loans 227.9 252.6 226.0 Lease liabilities 26.1 15.1 9.6 Deferred tax liabilities 33.8 34.5 33.1 Pension obligations 4.7 5.5 4.8 Other non-interest-bearing liabilities 8.2 9.9 8.6 Provisions 2.1 0.0 3.1 Total 302.8 317.6 285.3 Current liabilities Loans 2.4 4.8 5.0 Lease liabilities 9.5 10.5 9.0 Trade and other payables 248.0 251.2 245.3 Total 259.8 266.4 259.3 Total liabilities 562.7 584.0 544.6 Total equity and liabilities 1,030.9 1,020.7 999.4 Consolidated statement of changes in equity Equity attributable to the shareholders of the parent company Non- Total Share Other Inv. Trans Retained Total cont equity capital funds non-rest. lation earnings equity diff. fund * rolling inte rests EUR million Equity 1.1.2025 48.1 -1.4 238.8 -21.1 138.1 402.4 21.3 423.7 Profit for the period 7.9 7.9 0.5 8.4 Other comprehensive income Cash flow hedges -0.4 -0.4 -0.4 Actuarial gains from pension benefits 0.0 0.0 0.0 Currency translation differences 5.8 5.8 5.8 Changes in shares of non-controlling interest -0.8 -0.8 0.0 -0.8 Equity 31.3.2025 48.1 -1.8 238.8 -15.3 145.1 414.9 21.8 436.6 Equity 1.1.2026 48.1 0.1 238.8 -15.0 160.0 432.0 22.8 454.8 Profit for the period 9.8 9.8 0.7 10.5 Other comprehensive income Cash flow hedges 3.9 3.9 3.9 Actuarial loss from pension benefits 0.0 0.0 0.0 Currency translation differences -1.3 -1.3 -1.3 Changes in shares of non-controlling interest 0.2 0.2 0.2 Share-based payments 0.2 0.2 0.2 Equity 31.3.2026 48.1 4.0 238.8 -16.3 170.2 444.7 23.5 468.2 * Includes the value of own shares EUR-0.3 million (31.12.2025 EUR -0.7 million). Consolidated cash flow statement EUR million 1-3/2026 1-3/2025 1-12/2025 Cash flow from operating activities Operating activities before financial items and taxes 2.0 22.6 138.2 Financial items and taxes -6.9 -5.1 -18.2 Net cash flow from operating activities -4.9 17.5 120.0 Cash flow from investing activities Investments in tangible and intangible assets -19.3 -8.5 -54.1 Proceeds from the sale of tangible and intangible assets 0.2 0.3 1.0 Investments in shares of associates -2.8 0.0 0.0 Increase (-) / decrease (+) in long-term receivables 0.6 3.2 3.2 Increase (-) / decrease (+) in short-term receivables -1.1 -0.9 -0.8 Dividends received 0.0 0.0 0.4 Net cash flow from investing activities -22.5 -5.9 -50.2 Cash flow from financing activities Proceeds from long-term borrowings 2.6 0.0 6.0 Repayment of long-term borrowings -2.4 -3.3 -33.5 Proceeds/repayments from short-term loans * -1.0 2.3 0.2 Principal elements of lease payments -2.7 -2.7 -10.6 Dividends paid / Capital refund 0.0 0.0 -20.8 Net cash flow from financing activities -3.5 -3.7 -58.7 Change in liquid funds -30.9 8.0 11.1 Cash and cash equivalents at beginning of year 30.9 19.9 19.9 Effect of exchange rate changes on cash flows 0.3 -0.4 -0.1 Cash and cash equivalents at the end of period 0.3 27.5 30.9 * Withdrawals and repayments of short-term loans include those with a maturity of more than 90 days commercial paper withdrawals and repayments. Withdrawals and repayments of commercial papers with a maturity of 90 days or less have been processed in the financial calculation on a net basis. Notes to the interim report Interim report accounting principles This interim report was prepared in accordance with the IAS 34 standard for interim reports. Atria has applied the same accounting principles to this interim report as to the 2025 annual financial statements. However, as of 1 January 2026, the Group has been applying the new or revised IFRS standards and IFRIC interpretations published by the IASB, mentioned in the description of the accounting principles for the annual financial statements for 2025. The preparation of the interim report in accordance with the IFRS requires the Group's management to use estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses. In addition, discretion must be used when applying the accounting principles. The estimates and assumptions are based on the views at the end of the reporting period and involve risks and uncertainties. The realised values may differ from the estimates and assumptions. The key accounting estimates and discretionary decisions are presented in more detail in the accounting principles for the 2025 consolidated financial statements. The formulae for calculating the key indicators are presented at the end of the report. In the company's view, the indicators presented serve to clarify the view provided by the income statement and balance sheet of the operational result and the financial position. The figures presented in the release are rounded to EUR million, so the combined total of individual figures may differ from the total sum presented. The figures presented in this interim report are unaudited. Operating segments EUR million 1-3/2026 1-3/2025 1-12/2025 Revenue from consumer goods Atria Finland 255.9 234.8 1,013.3 Atria Sweden 93.4 88.9 392.7 Atria Denmark & Estonia 29.0 29.8 124.8 Eliminations -4.9 -6.0 -23.3 Total 373.4 347.6 1,507.5 Revenue from primary products Atria Finland 76.9 72.9 306.3 Atria Sweden - - - Atria Denmark & Estonia - - - Unallocated - - - Total 76.9 72.9 306.3 Total net sales 450.3 420.5 1,813.7 EBIT * Atria Finland 10.7 11.2 56.3 Atria Sweden 1.5 0.7 8.3 Atria Denmark & Estonia 2.6 1.8 4.9 Unallocated -0.8 -0.9 -5.5 Total 13.9 12.8 64.0 Adjusted EBIT Atria Finland 10.7 11.2 62.2 Atria Sweden 1.5 0.7 8.3 Atria Denmark & Estonia 2.6 1.8 4.9 Unallocated -0.8 -0.9 -5.5 Total 13.9 12.8 69.9 Investments Atria Finland 14.7 4.5 37.6 Atria Sweden 4.0 1.7 11.4 Atria Denmark & Estonia 0.4 2.2 5.2 Total 19.1 8.4 54.2 Depreciation and write-offs Atria Finland 11.5 11.0 45.8 Atria Sweden 3.8 3.3 13.7 Atria Denmark & Estonia 1.2 1.2 5.0 Total 16.6 15.6 64.5 * Items affecting comparability are detailed on page 2. Fair value hierarchy of financial assets and liabilities EUR million Balance sheet items 31.3.2026 Level 1 Level 2 Level 3 Assets Financial assets at fair value through other comprehensive income 3.7 3.7 Derivative financial instruments 7.0 7.0 Total 10.7 0.0 7.0 3.7 Liabilities Derivative financial instruments 0.9 0.9 Total 0.9 0.0 0.9 0.0 Balance sheet items 31.12.2025 Level 1 Level 2 Level 3 Assets Financial assets at fair value through other comprehensive income 3.7 3.7 Derivative financial instruments 1.5 1.5 Total 5.2 0.0 1.5 3.7 Liabilities Derivative financial instruments 1.7 1.7 Total 1.7 0.0 1.7 0.0 There were no transfers between Levels 1 and 2 during the period. Level 1: Prices listed on active markets for identical assets and liabilities. Level 2: Fair values can be determined either directly (i.e., as prices) or indirectly (i.e., derived from prices). Level 3: Fair values are not based on verifiable market prices. Fair values of financial instruments do not deviate significantly from balance sheet values. Related party transactions EUR million The following transactions were completed with related parties: 1-3/2026 1-3/2025 1-12/2025 Sales 5.2 6.6 28.2 Purchases * -27.5 -27.6 -118.0 Interest income 0.0 0.0 0.1 31.3.2026 31.3.2025 31.12.2025 Receivables 2.6 2.3 2.4 Liabilities 6.3 7.0 6.9 *Purchases for the period 1-12/2025 include a non-recurring item of EUR 1.0 million related to the disposal of the Kelloniemi factory site in Kuopio. The related-party transactions account for only EUR 1.0 million of the total costs of EUR 5.9 million. Contingent liabilities EUR million 31.3.2026 31.3.2025 31.12.2025 Debts with mortgages given as security Loans from financial institutions 9.0 5.4 8.8 Pension fund loans 4.5 4.8 4.5 Total 13.5 10.2 13.3 Mortgages given as comprehensive security Real estate mortgages 10.6 5.6 10.6 Corporate mortgages 3.6 2.5 3.6 Total 14.2 8.1 14.2 Guarantee engagements not included in the balance sheet Guarantees 7.3 0.1 7.3 FINANCIAL INDICATORS In addition to the IFRS figures, Atria publishes other widely used alternative financial indicators that can be derived from the income statement and balance sheet. Principles for calculating financial indicators: Adjusted EBIT, In addition to reporting EBIT, profit before taxes and profit for the period adjusted profit before taxes the company publishes an adjusted EBIT, adjusted profit before taxes and and adjusted profit for the period adjusted profit for the period indicators to describe the actual financial development of the business and to improve comparability between periods. The adjusted figures are determined by adjusting the above items for material items that affect comparability. These may include events that are not part of ordinary business activities, such as the restructuring of operations, capital gains and losses attributable to the sale of operations, Gross investments = Investments in tangible and intangible assets Free cash flow = Cash flow from operating activities - Cash flow from investments FTE = Hours worked during the review period Number of working days during the review period * normal working hours per day Return on equity (%) = Profit/loss for the period * 100 Equity (average) Adjusted return = Adjusted profit/loss for the period * 100 on equity (%) Equity (average) Adjusted return = Adjusted profit/loss for the period, rolling 12m * 100 on equity (%), rolling 12m Equity (average 12m) Return on investment (%) = Profit/loss before tax + interest and other financial expenses * 100 Equity + interest-bearing financial liabilities (average) Adjusted return = Adjusted profit/loss before tax + interest and other financial expenses * 100 on investment (%) Equity + interest-bearing financial liabilities (average) Adjusted return = Adjusted profit/loss before tax + interest and other financial expenses, rolling 12m * 100 on investment (%), rolling 12m Equity + interest-bearing financial liabilities (average 12m) Equity ratio (%) = Shareholders' equity * 100 Balance sheet total - advance payments received Interest-bearing liabilities = Loans + lease liabilities Gearing (%) = Interest-bearing liabilities * 100 Shareholders' equity Net interest-bearing liabilities = Interest-bearing liabilities - cash and cash equivalents Net gearing (%) = Interest-bearing liabilities - cash and cash equivalents * 100 Shareholders' equity Adjusted EBITDA = Adjusted EBIT + depreciations and write-offs Net dept to EBITDA, adjusted = Net dept at the period end rolling 12m Adjusted EBITDA, rolling 12m Earnings per share (basic) = Profit for the period attributable to the owners of the parent company Weighted average of outstanding shares Adjusted earnings = Adjusted profit for the period attributable to the owners of the parent company per share (basic) Weighted average of outstanding shares Equity/share = Equity attributable to the owners of the parent company Undiluted number of outstanding shares at the period end Dividend per share = Dividend distribution during the period Undiluted number of shares at the period end Dividend/profit (%) = Dividend/share * 100 Earnings per share (EPS) Adjusted dividend/profit (%) = Dividend/share * 100 Adjusted earnings per share (Adjusted EPS) Effective dividend yield (%) = Dividend/share * 100 Closing price at the end of the period Price/earnings (P/E) = Closing price at the end of the period Earnings per share Adjusted price/earnings (P/E) = Closing price at the end of the period Adjusted earnings per share Average price = Overall share turnover in euro Undiluted average number of shares traded during the period Market capitalisation = Number of shares at the end of the period * closing price at the period end Share turnover (%) = Number of shares traded during the period * 100 Undiluted average number of series A shares